Patient selection for subcutaneous versus sublingual immunotherapy

Abstract

With the improvement of SL-AIT efficacy, the selection of SC-versus-SL-AIT will probably increasingly be based not on efficacy, but on practical aspects, without losing sight of which SL-AIT products have proven efficacy.

Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real‐life study

“…Several factors such as treatment schedule, lack of efficacy, and inadequate insurance coverage have been reported to affect the compliance . However, there is great variation regarding AIT adherence and reasons for nonadherence in different regions . It is crucial to figure out the level of real‐life adherence in the region even in 1 hospital and to engage communication tools to maximize adherence.…”